Anti-factor Xa Activity Is Not Associated With Venous Thromboembolism in Critically Ill Patients Receiving Enoxaparin for Thromboprophylaxis: A Retrospective Observational Study

Anti-factor Xa Activity Is Not Associated With Venous Thromboembolism in Critically Ill Patients Receiving Enoxaparin for Thromboprophylaxis: A Retrospective Observational Study

BackgroundAnti-factor Xa activity has been suggested as a surrogate parameter for judging the effectiveness of pharmacological thromboprophylaxis with low molecular weight heparins in critically ill patients. However, this practice is not supported by evidence associating low anti-factor Xa activity...

Full description

Bibliographic Details
Main Authors: Christoph Dibiasi, Johannes Gratz, Marion Wiegele, Andreas Baierl, Eva Schaden
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-04-01
Series:Frontiers in Medicine
Subjects:
anti-factor Xa activity
low molecular weight heparin
thromboprophylaxis
venous thromboembolism
critical illness
anticoagulation
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2022.888451/full

Internet

https://www.frontiersin.org/articles/10.3389/fmed.2022.888451/full

Similar Items